Oral Contraceptive Clinical Trial
Official title:
Comparative, Prospective, Multi-Center, Open, Randomized Study to Investigate Bleeding Patterns, Metabolic Effects, Contraceptive Efficacy, Acceptance, and Safety of an Oral Contraceptive Containing 0.03 mg Ethinylestradiol and 2 mg Dienogest, in Two Different Regimens of Intake (Four Extended Cycles of 84 Days Each Versus the Conventional Regimen of 21 Days) in Healthy Volunteers
The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake.
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been
renamed to Bayer Schering Pharma AG, Germany.
Bayer Schering Pharma AG, Germany is the sponsor of the trial.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01388491 -
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
| Completed |
NCT01252186 -
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
| Not yet recruiting |
NCT06426459 -
Social Media Usage in Adolescent Girls
|
||
| Recruiting |
NCT02398903 -
Evaluation of Hormonal Contraceptive Treatments in Obese Women
|
||
| Completed |
NCT00739622 -
TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
|
Phase 1 | |
| Completed |
NCT01291004 -
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
|
Phase 1 | |
| Recruiting |
NCT01318005 -
Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation
|
N/A | |
| Recruiting |
NCT02021097 -
Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception
|
Phase 3 | |
| Completed |
NCT00778609 -
Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
|
Phase 3 | |
| Completed |
NCT00972439 -
Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
|
N/A | |
| Completed |
NCT01076582 -
Comparative Trial in Hormone Withdrawal Associated Symptoms
|
Phase 3 | |
| Completed |
NCT00471991 -
Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition
|
Phase 2 | |
| Completed |
NCT00248963 -
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
|
Phase 3 |